YCBD
cbdMD Inc
NYSE MKT: YCBD · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.85
-2.02% today
Updated 2026-04-30
Market cap
$10.18M
P/E ratio
1.62
P/S ratio
0.53x
EPS (TTM)
$0.60
Dividend yield
—
52W range
$0 – $3
Volume
1.8M
cbdMD Inc (YCBD) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$0.85
12-Month target
$0.74
2030 Target
—
Intrinsic (DCF)
$3.16
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 1.62x (capped 25x) · Margin: -12.20%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.